{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:10:54Z","timestamp":1791378654251,"version":"4.3.2"},"reference-count":20,"publisher":"Jaypee Brothers Medical Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.59556\/japi.74.1444","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:17:45Z","timestamp":1773379065000},"page":"68-74","source":"Crossref","is-referenced-by-count":2,"title":["Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study"],"prefix":"10.59556","volume":"74","author":[{"given":"Vimal","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratishtha","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navya","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Dabla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Sukhija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safal","family":"Safal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Kathuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Barton","family":"Duell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KK","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"issue":"(3):","key":"key20260313051738_B1","doi-asserted-by":"crossref","first-page":"267\u2013","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).","volume":"37","author":"Roffi","year":"2016;","journal-title":"Eur Heart J"},{"issue":"(3):","key":"key20260313051738_B2","doi-asserted-by":"crossref","first-page":"261\u2013","DOI":"10.1016\/j.jacl.2022.03.008","article-title":"Evidence for intensive LDL-C lowering for acute coronary syndrome: recommendations from the Lipid Association of India.","volume":"16","author":"Puri","year":"2022;","journal-title":"J Clin Lipidol"},{"key":"key20260313051738_B3","doi-asserted-by":"crossref","first-page":"581\u2013","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.","volume":"380:","author":"Mihaylova","year":"2012;","journal-title":"Lancet"},{"key":"key20260313051738_B4","doi-asserted-by":"crossref","first-page":"1670\u2013","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.","volume":"376:","author":"Baigent","year":"2010;","journal-title":"Lancet"},{"issue":"(13):","key":"key20260313051738_B5","doi-asserted-by":"crossref","first-page":"1711\u2013","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.","volume":"285","author":"Schwartz","year":"2001;","journal-title":"JAMA"},{"issue":"(8):","key":"key20260313051738_B6","doi-asserted-by":"crossref","first-page":"1405\u2013","DOI":"10.1016\/j.jacc.2005.03.077","article-title":"Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.","volume":"46","author":"Ray","year":"2005;","journal-title":"J Am Coll Cardiol"},{"key":"key20260313051738_B7","doi-asserted-by":"crossref","first-page":"1272\u2013","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.","volume":"49:","author":"Patti","year":"2007;","journal-title":"J Am Coll Cardiol"},{"key":"key20260313051738_B8","doi-asserted-by":"crossref","first-page":"2387\u2013","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes.","volume":"372:","author":"Cannon","year":"2015;","journal-title":"N Engl J Med"},{"key":"key20260313051738_B9","doi-asserted-by":"crossref","first-page":"2097\u2013","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome.","volume":"379:","author":"Schwartz","year":"2018;","journal-title":"N Engl J Med"},{"issue":"(20):","key":"key20260313051738_B10","doi-asserted-by":"crossref","first-page":"2452\u2013","DOI":"10.1016\/j.jacc.2019.08.010","article-title":"Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS).","volume":"74","author":"Koskinas","year":"2019;","journal-title":"J Am Coll Cardiol"},{"issue":"(18):","key":"key20260313051738_B11","doi-asserted-by":"crossref","first-page":"1771\u2013","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial.","volume":"327","author":"Raber","year":"2022;","journal-title":"JAMA"},{"issue":"(3):","key":"key20260313051738_B12","doi-asserted-by":"crossref","first-page":"237\u2013","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction.","volume":"40","author":"Thygesen","year":"2019;","journal-title":"Eur Heart J"},{"issue":"(19):","key":"key20260313051738_B13","doi-asserted-by":"crossref","first-page":"1163\u2013","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide real-world data demonstrate the importance of a long-term perspective.","volume":"36","author":"Jernberg","year":"2015;","journal-title":"Eur Heart J"},{"issue":"(12):","key":"key20260313051738_B14","doi-asserted-by":"crossref","first-page":"1852\u2013","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture.","volume":"114","author":"Bentzon","year":"2014;","journal-title":"Circ Res"},{"issue":"(23 Suppl 1):","key":"key20260313051738_B15","first-page":"III39\u2013","article-title":"Beneficial cardiovascular pleiotropic effects of statins.","volume":"109","author":"Davignon","year":"2004;","journal-title":"Circulation"},{"issue":"(9411):","key":"key20260313051738_B16","first-page":"757\u2013","article-title":"Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.","volume":"363","author":"Collins","year":"2004;","journal-title":"Lancet"},{"issue":"(7):","key":"key20260313051738_B17","doi-asserted-by":"crossref","first-page":"1225\u2013","DOI":"10.1016\/j.jacc.2005.07.006","article-title":"The forgotten majority: unfinished business in cardiovascular risk reduction.","volume":"46","author":"Libby","year":"2005;","journal-title":"J Am Coll Cardiol"},{"key":"key20260313051738_B18","doi-asserted-by":"crossref","first-page":"111\u2013","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.","volume":"41:","author":"Mach","year":"2020;","journal-title":"Eur Heart J"},{"key":"key20260313051738_B19","first-page":"e1082\u2013","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"139:","author":"Grundy","year":"2019;","journal-title":"Circulation"},{"issue":"(4):","key":"key20260313051738_B20","doi-asserted-by":"crossref","first-page":"419\u2013","DOI":"10.1161\/CIRCULATIONAHA.120.046320","article-title":"Effect of evolocumab on atherogenic lipoproteins during the peri- and early postinfarction period: a placebo-controlled, randomized trial.","volume":"142","author":"Leucker","year":"2020;","journal-title":"Circulation"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:17:48Z","timestamp":1773379068000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-3-68"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.59556\/japi.74.1444"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1444","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}